AT&T Waives $19 LifeMD Fee for 100 Million Wireless and Fiber Customers

AT&T is partnering with LifeMD to waive its $19 monthly membership fee for over 100 million wireless and fiber customers, making it the first carrier to bundle no-cost virtual healthcare access. The rollout begins in 11 states, with the rest following in January 2027. LifeMD (LFMD) provides telehealth services, and AT&T aims to enhance customer retention. AT&T's stock is valued at $29.03 per share, with projected slight earnings declines due to heavy capital spending.

Original reporting
Published Sep 16, 2026, 12:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 4:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$T
Bullish
high confidence
Mentioned
$T · $LFMD
Relevance
7/10
AlphAI data visualization · based on kobaran.com
Decision brief

The 30-second read

$TBullishMed
01

Why it matters

The partnership could enhance AT&T's stickiness while providing LifeMD with a large distribution channel, though financial upside depends on utilization.

02

Market read

A strategic partnership that may influence telecom subscriber dynamics and telehealth growth prospects.

03

What to watch

Potential regulatory scrutiny on telecom‑health bundling and the actual enrollment conversion rate.

Relevance 7/10Novelty 7/10Timing: announced Sep 15 2026

Background

AT&T is expanding its consumer platform strategy by integrating health services to reduce churn.

Company-level read

Ticker impact

$TBullishHigh confidence
Context

AT&T announced a partnership to waive the $19 monthly LifeMD fee for its 100M wireless and fiber customers.

Expected impact

Slight upside pressure on T as investors view the perk as a competitive advantage.

Evidence & confidence

Large-cap telecom adding a consumer‑focused benefit; market typically rewards subscriber‑sticky initiatives.

$LFMDBullishMedium confidence
Context

LifeMD secured a partnership giving access to AT&T’s 100M customers, expanding its addressable market.

Expected impact

Potential upside for LFMD as market prices in new volume opportunity.

Evidence & confidence

Revenue impact depends on enrollment rates; partnership is a significant distribution channel.

Market effects

Telecom sector may see increased competition on value‑added services; other carriers could launch similar perks.

U.S. market, especially telecom and telehealth subsectors, may experience modest re‑rating.

Limited to U.S. investors; no immediate global macro effect.

Counterpoint

The added cost of care visits could offset subscriber benefits, leading to limited net impact on AT&T margins.

Key entities

  • AT&T

    U.S. telecom giant offering the waived fee benefit.

  • LifeMD

    Nasdaq‑listed telehealth provider gaining access to AT&T customers.

Related articles

$TMed

N.J. faces major job cuts as AT&T builds $1.35B Texas headquarters

AT&T is building a $1.35B headquarters in Texas while cutting 350 jobs in New Jersey. The company plans to move employees to the new Plano campus by 2028, consolidating Dallas-Fort Worth teams. AT&T has been reducing its workforce and real estate in New Jersey, with recent layoffs in Monmouth, Somerset, and Cumberland counties.

$LFMDMed

LifeMD Nov 2026 slides: platform scale grows amid revenue reset

LifeMD (LFMD) presented its investor deck, highlighting revenue growth from $11M in 2019 to an expected $190M in 2026. Q3 revenue missed expectations at $44.6M, and the stock fell 17.59%. The company emphasized its telehealth platform's scale, AI integration, and nationwide pharmacy infrastructure, serving 350,000 active patients. LifeMD reset 2026 guidance to $188M-$191M revenue and negative EBITDA, citing delayed GLP-1 fulfillment and reduced marketing.

$LFMDMed

Why is LifeMD stock sliding today?

LifeMD (LFMD) stock fell 9.4% after reporting Q3 2026 revenue of $44.6M, missing estimates of $48.9M. The company cut its full-year revenue outlook to $188M-$191M and widened its EBITDA loss forecast. Additionally, an accounting investigation and securities inquiry weighed on sentiment.

$LFMDMed

LifeMD Reports Third Quarter 2026 Results

LifeMD, Inc. (LFMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 LifeMD Reports Third Quarter 2026 Results ● Third quarter 2026 revenue of $44.6 million; adjusted EBITDA loss of approximately $0.4 million, within the Company’s guidance range of negative $1 million to positive $2 million. ● Adjusted EBITDA improved approximately $3

$SPCXMed

Verizon, AT&T and T-Mobile shut out Elon Musk’s phone service. Now the FCC is reviewing SpaceX’s plan to build its own

The FCC is reviewing SpaceX's $8B plan to buy 800 MHz licenses, aiming to provide nationwide mobile broadband. Verizon, AT&T, and T-Mobile opposed, citing potential network impacts. SpaceX claims this will ensure full U.S. coverage, with Starlink Mobile combining satellite and terrestrial networks. FCC approval is uncertain, with public comments due in December.